483 Eli Lilly and Company Feb 2013

483 Eli Lilly and Company Feb 2013

Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly and Company - Indianapolis, IN, United States facility and issued 1 inspectional observation (via FDA 483) on 14 Feb 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 14 Feb 2013
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart